Cambridge Health Alliance
Cambridge, Massachusetts, 02139, United States
NCT Number: NCT02192593
This is a randomized controlled trial, examining the effects of a computerized, internet-based Cognitive Behavioral Therapy (CBT) Intervention for persons with a schizophrenia spectrum disorder who experience distressing auditory hallucinations (voices). Participants are randomized to one of two conditions: either to receive the 10-session computer-based program on a weekly basis, or to their usual care at their mental health clinic. This study takes place at Cambridge Health Alliance in Cambridge Massachusetts. It is hypothesized that the participants who participate in the CBT program will have significant improvements in the severity of their auditory hallucinations, as well as their associated distress, compared to the participants receiving usual care.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Cambridge, Massachusetts, 02139, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline, Post-Treatment, 3-Month Follow-up
Primary outcome is change in BPRS hallucinations item from baseline to post-treatment to 3 month follow-up. This measure assesses severity of auditory hallucinations as well as overall psychiatric symptoms
Boston University Charles River Campus
Other
Randomized Controlled Trial of Computerized Cognitive Behavioral Therapy for Auditory Hallucinations in Persons With Psychosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06319170
Mental Disorders, Psychotic Disorders
Los Alamitos, California, United States
View Trial DetailsNCT04512066
Mental Disorders, Psychotic Disorders
Little Rock, Arkansas, United States
View Trial DetailsNCT00224315
Mental Disorders, Psychotic Disorders
Mannheim, Baden-Wurttemberg, Germany
View Trial DetailsNCT02808533
Mental Disorders, Psychotic Disorders
Toronto, Ontario, Canada
View Trial Details